MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,293 Cr | ₹1,110 Cr | ₹1,070 Cr | ₹858 Cr | ₹663 Cr |
What is the latest Total Liabilities ratio of MOREPEN LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹1,293 Cr |
Mar2023 | ₹1,110 Cr |
Mar2022 | ₹1,070 Cr |
Mar2021 | ₹858 Cr |
Mar2020 | ₹663 Cr |
How is Total Liabilities of MOREPEN LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,293 Cr | 16.45 | |
Mar2023 | ₹1,110 Cr | 3.78 | |
Mar2022 | ₹1,070 Cr | 24.69 | |
Mar2021 | ₹858 Cr | 29.34 | |
Mar2020 | ₹663 Cr | - |
Compare Total Liabilities of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹2,889.1 Cr | 4.3% | 6.7% | 17.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,706.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,946.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹120,751.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,988.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,066.7 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | 4.3% |
6.7% |
17.4% |
SENSEX | -1.3% |
4.2% |
3.6% |
You may also like the below Video Courses